Alnylam Files Trade Secret Misappropriation Suit Against Dicerna Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/1/2026
- Wall St set for higher open tech gains offset bond-market jitters
- Oil prices rise as China suspends fuel exports
- Amazon and these four U.S. stocks are latest additions to Goldman’s flagship list
- Elevated equity positioning, leverage could challenge stocks in Q4: JPMorgan
- Alphabet shares up in premarket trade after Gemini 4 Argon launch
- Zimbabwe helicopter crash kills six, government spokesperson says
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- S&P 500 dips, Nasdaq higher after data shows moderate inflation rise
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
Dicerna Pharma (DRNA) Calls Alnylam (ALNY) Claims Poppycock
June 11, 2015 7:31 AM EDTDicerna Pharma (NASDAQ: DRNA) responded to a complaint filed yesterday by Alnylam Pharma (NASDAQ: ALNY) in the Superior Court of Middlesex County, Massachusetts. Dicerna believes the complaint is meritless and that Alnylam precipitously filed its lawsuit based on assumptions rather than facts.... More
Alnylam Pharma (ALNY) Sues Dicerna Pharma (DRNA) Over Trade Secret Misappropriation Allegations
June 10, 2015 4:01 PM EDTAlnylam Pharma (NASDAQ: ALNY) that it has filed a trade secret misappropriation lawsuit against Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) in the Superior Court of Middlesex County, Massachusetts. By this lawsuit, Alnylam seeks to stop misappropriation by Dicerna of the... More
